Form: SCHEDULE 13G

Statement of Beneficial Ownership by Certain Investors

February 17, 2026






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The issuer changed its name from Mind Medicine (MindMed), Inc. to Definium Therapeutics, Inc. on January 12, 2026.


SCHEDULE 13G



 
DRIEHAUS CAPITAL MANAGEMENT LLC
 
Signature:Janet McWilliams
Name/Title:Janet McWilliams/General Counsel
Date:02/17/2026